295 related articles for article (PubMed ID: 19814949)
1. Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models.
Lin CC; Bai YM; Chen JY; Hwang TJ; Chen TT; Chiu HW; Li YC
J Clin Psychiatry; 2010 Mar; 71(3):225-34. PubMed ID: 19814949
[TBL] [Abstract][Full Text] [Related]
2. Body mass index as a screening test for metabolic syndrome in schizophrenia and schizoaffective disorders.
Tirupati S; Chua LE
Australas Psychiatry; 2007 Dec; 15(6):470-3. PubMed ID: 17999257
[TBL] [Abstract][Full Text] [Related]
3. Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?
Van Schependom J; Yu W; Gielen J; Laton J; De Keyser J; De Hert M; Nagels G
J Clin Psychiatry; 2015 Oct; 76(10):e1292-9. PubMed ID: 26528652
[TBL] [Abstract][Full Text] [Related]
4. HIV lipodystrophy case definition using artificial neural network modelling.
Ioannidis JP; Trikalinos TA; Law M; Carr A;
Antivir Ther; 2003 Oct; 8(5):435-41. PubMed ID: 14640391
[TBL] [Abstract][Full Text] [Related]
5. Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical data.
Lin CC; Wang YC; Chen JY; Liou YJ; Bai YM; Lai IC; Chen TT; Chiu HW; Li YC
Comput Methods Programs Biomed; 2008 Aug; 91(2):91-9. PubMed ID: 18508152
[TBL] [Abstract][Full Text] [Related]
6. Appropriateness guidelines and predictive rules to select patients for upper endoscopy: a nationwide multicenter study.
Buri L; Hassan C; Bersani G; Anti M; Bianco MA; Cipolletta L; Di Giulio E; Di Matteo G; Familiari L; Ficano L; Loriga P; Morini S; Pietropaolo V; Zambelli A; Grossi E; Intraligi M; Buscema M;
Am J Gastroenterol; 2010 Jun; 105(6):1327-37. PubMed ID: 20029414
[TBL] [Abstract][Full Text] [Related]
7. Comparison between neural networks and multiple logistic regression to predict acute coronary syndrome in the emergency room.
Green M; Björk J; Forberg J; Ekelund U; Edenbrandt L; Ohlsson M
Artif Intell Med; 2006 Nov; 38(3):305-18. PubMed ID: 16962295
[TBL] [Abstract][Full Text] [Related]
8. Prediction of low bone mineral density in postmenopausal women by artificial neural network model compared to logistic regression model.
Ongphiphadhanakul B; Rajatanavin R; Chailurkit L; Piaseu N; Teerarungsikul K; Sirisriro R; Komindr S; Pauvilai G
J Med Assoc Thai; 1997 Aug; 80(8):508-15. PubMed ID: 9277083
[TBL] [Abstract][Full Text] [Related]
9. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
10. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
Schneiderhan ME; Batscha CL; Rosen C
Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
[TBL] [Abstract][Full Text] [Related]
11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
12. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
13. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up.
Medved V; Kuzman MR; Jovanovic N; Grubisin J; Kuzman T
J Psychopharmacol; 2009 Nov; 23(8):915-22. PubMed ID: 18635691
[TBL] [Abstract][Full Text] [Related]
15. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
[TBL] [Abstract][Full Text] [Related]
16. The use of neural networks and logistic regression analysis for predicting pathological stage in men undergoing radical prostatectomy: a population based study.
Borque A; Sanz G; Allepuz C; Plaza L; Gil P; Rioja LA
J Urol; 2001 Nov; 166(5):1672-8. PubMed ID: 11586200
[TBL] [Abstract][Full Text] [Related]
17. Can we improve the prediction of stone-free status after extracorporeal shock wave lithotripsy for ureteral stones? A neural network or a statistical model?
Gomha MA; Sheir KZ; Showky S; Abdel-Khalek M; Mokhtar AA; Madbouly K
J Urol; 2004 Jul; 172(1):175-9. PubMed ID: 15201765
[TBL] [Abstract][Full Text] [Related]
18. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.
Morrato EH; Cuffel B; Newcomer JW; Lombardo I; Kamat S; Barron J
J Clin Psychopharmacol; 2009 Feb; 29(1):26-32. PubMed ID: 19142103
[TBL] [Abstract][Full Text] [Related]
19. Application of artificial neural networks to establish a predictive mortality risk model in children admitted to a paediatric intensive care unit.
Chan CH; Chan EY; Ng DK; Chow PY; Kwok KL
Singapore Med J; 2006 Nov; 47(11):928-34. PubMed ID: 17075658
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
Brunero S; Lamont S; Fairbrother G
Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
